InsidersTradesSigma
Discover the full record of transactions filed by Alkon Daniel L., Directeur Scientifique. Officer active across 1 companies, notably Synaptogenix, Inc.. Cumulatively, 4 filings have been logged. Total volume traded: €136k. The latest transaction was filed on 13 July 2021 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
4 of 4 declarations
Daniel L. Alkon serves as Chief Scientific Officer at Synaptogenix, Inc. He is responsible for leading the company's scientific and research initiatives, contributing to innovation and the development of new treatments. His scientific expertise is crucial for Synaptogenix's success.